THE HAGUE — The digital era is radically changing how technology is used, and new technologies are set to have major impacts on how people live and work. How pharmacists and pharmacy organizations can rise to the challenge of these technologies and embrace them is set out in a new Position Statement on emerging technologies
WEST DES MOINES, Iowa — Hy-Vee announced today that it is reinstating its reserved shopping hour for customers considered “high risk” in response to the recent increase in COVID-19 cases throughout its eight-state region. The reserved hour will be offered at all Hy-Vee locations from 7 a.m. to 8 a.m., Monday through Friday, and is
NEW YORK — Cardinal Health Inc. and AmerisourceBergen Corp. will be network administrators in the Federal Pharmacy Partnership Strategy for COVID-19, which will enable independent, small chain and long-term-care pharmacies to participate in the vaccination effort. McKesson Corp., which will be a centralized vaccine distributor, is preparing to carry out the Centers for Disease Control
WASHINGTON — The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease. The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild
DEERFIELD, Ill. — Walgreens president John Standley issued the following memo on Friday regarding how the company is supporting communities during the COVID-19 pandemic: “As the nation confronts a rising surge in COVID-19 cases, many Americans are faced with fear and uncertainty. But there is one thing you can remain certain of — Walgreens will
THE HAGUE— To help pharmacists advise people on COVID-19 tests, the International Pharmaceutical Federation (FIP), has issued a guidance document. The guidance has been produced by FIP’s SARS-CoV-2 Testing Working Group, which has evaluated the diagnostic testing methods and devices currently available. The document covers how different types of diagnostic test work and the interpretation
HATFIELD, Pa. — Nordic Cold Chain Solutions has developed a new line of Pre-Tested Frozen Shippers designed specifically to enable proper storage and distribution of vaccines, including the highly anticipated COVID vaccine(s). Nordic Express Pre-Tested Frozen Parcel Shippers are designed and tested to meet ISTA 7E requirements. These shippers are available in multiple sizes to
ARLINGTON, Va. — FMI – The Food Industry Association shares its pleasure that the federal government recognizes supermarket pharmacists – nationally and regionally – as essential partners in increasing future access to the COVID-19 vaccines. Leslie Sarasin, president and chief executive officer of FMI, offered comment in response to yesterday’s announcement by the U.S. Department of
ATLANTA — There’s no doubt that COVID-19 has changed the way we do business. Unfortunately, that change has enabled an increase in fraud for merchants and individuals. A recent study produced by LexisNexis Risk Solutions showed that in the U.S. and Canada, fraud costs companies $3.36 for every dollar lost to fraud, compared to $3.13
ALEXANDRIA, Va. — The National Community Pharmacists Association today welcomed indications that the federal Department of Health and Human Services and the Centers for Disease Control and Prevention are making COVID-19 vaccines available to community pharmacies through independent pharmacy network administrators and state health departments. “We are pleased that independent pharmacy groups will be included
WASHINGTON —President-elect Joe Biden and vice president-elect Kamala Harris announced Monday the public health experts that will be making up their COVID-19 advisory board once they take office in January. “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,”
INDIANAPOLIS — The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for Eli Lilly and Co. investigational neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. Bamlanivimab is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test, who are at high
NEW YORK — Pfizer announced on Monday that the vaccine the company jointly developed with BioNTech was 90% effective in preventing COVID-19 infections in ongoing Phase 3 trials. Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings. “The first set of
NEW YORK — With votes from this week’s presidential election still being counted and COVID-19 cases approaching the 10 million mark, a survey recently conducted by Reputation Leaders found six in 10 Americans reported both their health and finances were impacted by COVID-19. A survey of 1000 U.S. adults nationally found 47% of Americans had
